MedPath

To assess the efficacy of dexmedetomidine and levobupivacaine in tap block for Post operative pain

Phase 4
Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2023/07/055537
Lead Sponsor
Career institute of medical science and hospital
Brief Summary

A comparative evaluation of Efficacy of 0.5% levobupivacaine Versus 0.5% levobupivacaine with dexmedetomidine in Ultrasound guided transversus abdominis plane block for Post operative analgesia in patients undergoing abdominal surgeries

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
60
Inclusion Criteria

ASA grade I/II belonging to American Society of Anaesthesiologists (ASA) Age group 18 to 65 years Patient undergoing abdominal surgeries under general anesthesia/spinal anesthesia will enrolled in the study Patient willing to give consent.

Exclusion Criteria
  • Patients with history of : Allergy to LEVOBUPIVACAINE Body mass index >35 kg.m−2 Preoperative opioid or nonsteroidal anti-inflammatory drug treatment for chronic pain. Morbid obesity Cardiac disorders.
  • ischaemic heart disease, hypertension Renal dysfunction.
  • chronic renal failure,acute kidney disease. Pre-existing neurological deficits,psychiatric illness will be excluded from the study. If the laparoscopic surgery will be switched to open procedure, the patient will be excluded from the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Onset & duration of Sensory blockade18 months
Duration of post operative analgesia18 months
Visual analogue score18 months
Secondary Outcome Measures
NameTimeMethod
Postoperative rescue analgesic requirementSide effects or complications

Trial Locations

Locations (1)

Career institute of medical science and hospital

🇮🇳

Lucknow, UTTAR PRADESH, India

Career institute of medical science and hospital
🇮🇳Lucknow, UTTAR PRADESH, India
Dr Priyesh Bhaskar
Principal investigator
7985975077
drpriyeshlpsc@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.